首页> 外国专利> Constructive improvement introduced in coronary stent coated with biodegradable polymer with a restenosis inhibiting drugs

Constructive improvement introduced in coronary stent coated with biodegradable polymer with a restenosis inhibiting drugs

机译:在可生物降解的聚合物涂层的冠状动脉支架中引入具有建设性的改进,同时具有抑制再狭窄的药物

摘要

"Constructive improvement introduced in coronary stent coated with polu00ecmero biodegradable with medication inhibiting restenosis".With the differential that present a refinement in the PON to view of the spectrum of the structure of the stent perfected (), which is made from a tube of stainless steel.Specification L SS316, which permits, through studies of finite element analysis, the implementation of a cut design, which leads to the formation of a structure with a high potential for concentration.With the great power of flexibility and adding even high reliability as its resistance to structural stress, caused due to concentration of stress in areas subject to torsion.Such design obtained is composed of circumferential bands with hollow structures (A1) around the contour of a nominal diameter for that band.Where the union between two of these bands is by elements of the type laminasde connection (A2), arranged in an alternating between themselves, and the structures castings (A1),They show profile curvature (A3), minimizing the interference of the stent improved (a) with the interior of the coronary artery.Where the union between two or more structures castings (A1) or between the latter and the elements of the type blades of connection (A2), is the continuity of the stainless steel.Without the need for amendments of the type solders, allowing areas of inflection (A4) and (A5) are highly resistant to damage by the stress of the material.In addition, the request now claimed builds within the spectrum of the medium for elution (b), the use of a biodegradable polymer.Which in essence provides a composition with the polymers poly L - lactide, 50 / 50 poly DL - lactide - co glycolide, 75 / 25 poly lactide, L - co - caprolactone) and poly vinyl pyrrolidone,In four distinct layers of loading of the medication inhibiting restenosis (c).
机译:“在可生物降解,可抑制药物再狭窄的可降解聚乙烯涂层冠状动脉支架上进行的建设性改进”。通过对PON进行细化,以完善的支架结构光谱为基础的差异(由规格为L SS316的不锈钢管,通过对有限元分析的研究,可以实施切割设计,从而形成具有高浓缩潜能的结构。由于应力集中在受扭区域中而导致的结构应力抵抗力甚至具有很高的可靠性。获得的这种设计是由带有空心结构(A1)的圆周带组成,该圆周带围绕该带的公称直径轮廓。这些带中的两个之间是由laminasde连接类型(A2)组成的,彼此交替布置,并且结构铸件(A 1),它们显示轮廓曲率(A3),最大程度地减少了改善的支架(a)对冠状动脉内部的干扰。两个或多个结构铸件(A1)之间或后者与铸件之间的结合连接刀片(A2)的类型是不锈钢的连续性,无需修改类型的焊料,允许(A4)和(A5)的弯曲区域高度抵抗材料应力的损坏。另外,现在提出的要求建立在洗脱介质的范围内(b),是使用可生物降解的聚合物。从本质上讲,该组合物提供了具有以下聚合物的组合物:聚L-丙交酯,50 // 50聚DL-丙交酯-co乙交酯,75 / 25聚丙交酯,L-己内酯和聚乙烯基吡咯烷酮)在四个不同的药物装载层中抑制再狭窄(c)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号